Results 291 to 300 of about 98,662 (362)

Study participant impression of use and satisfaction with STS101 (dihydroergotamine nasal powder): Results from the open‐label ASCEND acute migraine study

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective/Background This study was undertaken to assess participants' impression of use and satisfaction with STS101 in a long‐term, open‐label safety study. The ASCEND study assessed the safety and tolerability of STS101, an investigational drug–device combination of 5.2 mg dihydroergotamine in a single‐use nasal delivery device for the ...
Jessica Ailani   +4 more
wiley   +1 more source

The Validation of the Persian Version of the ID-Migraine Questionnaire. [PDF]

open access: yesMed Sci (Basel)
Nasirzadeh A   +9 more
europepmc   +1 more source

Gepants for headache prevention in children and adolescents: A multicenter chart review study

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Introduction There is an unmet need for safe, evidence‐based pharmacologic treatments for migraine prevention in children and adolescents. Rimegepant and atogepant, calcitonin gene‐related peptide receptor antagonists (gepants), have been shown to be efficacious and well‐tolerated preventive treatments in adults with migraine.
Lauren Shin   +9 more
wiley   +1 more source

Chinook winds and migraine attack onset in children and adolescents: A prospective longitudinal clinical cohort study

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
ABSTRACT Objective To explore the relationship between migraine attack onset in children and adolescents and Chinooks, which are dry and warm westerly winds that generally occur in the winter and bring about abrupt weather changes to the east of the Rocky Mountains in Southern Alberta, Canada. Methods This was a prospective longitudinal clinical cohort
Rylan Heart Villaruz   +6 more
wiley   +1 more source

Long-term real-world effectiveness and safety of fremanezumab in 1140 patients with migraine and at least 6 months of treatment: third interim analysis of the pan-European PEARL study. [PDF]

open access: yesNeurol Sci
Ashina M   +15 more
europepmc   +1 more source

Episodic Migraine Pain Curves: Real-Time Smartphone-Based Analysis and Clinical Implications. [PDF]

open access: yesJ Pain Res
Gago-Veiga AB   +9 more
europepmc   +1 more source

Association between liver enzyme levels and prevalence of migraine: the atherosclerosis risk in communities study. [PDF]

open access: yesTher Adv Neurol Disord
Ruban A   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy